Safety Study of XP12B in Women With Menorrhagia

Completed · Phase 3

Conditions studied: Menorrhagia, Heavy Menstrual Bleeding

In brief

The purpose of this study is to evaluate the safety of XP12B in women with heavy menstrual bleeding associated with menorrhagia.

Key facts

Study ID

NCT00113568

Run by

Ferring Pharmaceuticals

People needed

784

Starts

2005-06-01

Expected to finish

2009-05-01

Last updated by the study team

2010-06-15

Who can join

Age: 18 and older, up to 49. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women with menorrhagia
• 18-49 years of age
• Regularly occuring menstrual periods

You may not qualify if…

• History or presence of clinically significant disease or abnormalities that might confound the study
• History of bilateral oophorectomy or hysterectomy

Where it is running

• Investigative Site — Fort Myers, Florida, United States
• Investigative Site — Miami, Florida, United States
• Investigative Site — New Port Richey, Florida, United States
• Investigative Site — Ocala, Florida, United States
• Investigative Site — Pinellas Park, Florida, United States
• Investigative Site — Venice, Florida, United States
• Investigative Site — West Palm Beach, Florida, United States
• Investigative Site — West Palm Beach, Florida, United States
• Investigative Site — Alpharetta, Georgia, United States
• Investigative Site — Roswell, Georgia, United States
• Investigative Site — Savannah, Georgia, United States
• Investigative Site — Savannah, Georgia, United States
• Investigative Site — Boise, Idaho, United States
• Investigative Site — Champaign, Illinois, United States
• Investigative Site — Evansville, Indiana, United States
• Investigative Site — Indianapolis, Indiana, United States
• Investigative Site — South Bend, Indiana, United States
• Investigative Site — Overland Park, Kansas, United States
• Investigative Site — Lexington, Kentucky, United States
• Investigative Site — Louisville, Kentucky, United States
• Investigative Site — Shreveport, Louisiana, United States
• Investigative Site — Portage, Michigan, United States
• Investigative Site — Chaska, Minnesota, United States
• Investigative Site — St Louis, Missouri, United States
• Investigative Site — Denver, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.